stockportfolio.pro
Novanta Inc. (NOVT)
Technology · Scientific & Technical Instruments · NasdaqGS
Novanta Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $384.76M | $521.29M | $614.34M | $626.10M | $590.62M | $706.79M | $860.90M | $881.66M | $949.25M | $980.60M |
| Gross profit | $162.45M | $220.53M | $261.53M | $262.08M | $244.52M | $300.33M | $378.47M | $399.90M | $421.55M | $435.28M |
| Net income | $22.00M | $60.05M | $49.11M | $40.77M | $44.52M | $50.33M | $74.05M | $72.88M | $64.09M | $53.83M |
| Net margin | 5.7% | 11.5% | 8.0% | 6.5% | 7.5% | 7.1% | 8.6% | 8.3% | 6.8% | 5.5% |
Source: Novanta Inc. SEC filings (10-K). 17 years of history available in the interactive view.
Explore 17 years of Novanta Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track NOVT in your portfolio →
About Novanta Inc.
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Novanta Inc. — frequently asked questions
What is Novanta Inc.'s revenue?
Novanta Inc. (NOVT) reported revenue of $980.60M for fiscal year 2025, up 3.3% from the prior year, according to its SEC filings.
Is Novanta Inc. profitable?
Yes. NOVT earned net income of $53.83M in fiscal 2025, a net margin of 5.5%.
What is NOVT's P/E ratio?
Novanta Inc. trades at a price-to-earnings ratio of about 110.8 based on the latest data in our nightly-refreshed cache.
How fast is Novanta Inc. growing?
NOVT's revenue grew at roughly 10.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
Where does this data come from?
All figures are computed from Novanta Inc.'s official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.